化学、製造、制御サービスのアウトソーシングの世界市場

化学、製造、制御サービスのアウトソーシングの世界市場は2030年までに140億米ドルに達する見込み

2024年に100億米ドルと推定される化学、製造、制御サービスのアウトソーシングの世界市場は、2024年から2030年にかけてCAGR 5.9%で成長し、2030年には140億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるAPIタイプは、CAGR 6.7%を記録し、分析期間終了時には76億米ドルに達すると予測されます。完成医薬品製剤セグメントの成長率は、分析期間中CAGR 5.3%と推定されます。

米国市場は27億米ドルと推定、中国はCAGR 9.4%で成長予測

米国の化学、製造、制御サービスのアウトソーシング市場は、2024年には27億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.8％と5.8％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の化学、製造、制御サービスのアウトソーシング市場- 主要動向と促進要因のまとめ

CMCサービスのアウトソーシング需要が増加している理由

医薬品開発と規制遵守の複雑化が、CMCサービスのアウトソーシング需要を促進しています。製薬会社やバイオテクノロジー企業は、品質と安全性の基準を確保しつつ、医薬品承認までの期間を短縮しなければならないというプレッシャーの高まりに直面しています。その結果、CMCサービスのアウトソーシングは戦略的ソリューションとして台頭し、企業は創薬や商品化といったコアコンピタンスに集中する一方で、製造・管理プロセスを専門の第三者プロバイダーに委ねることができるようになりました。さらに、生物製剤、バイオシミラー、個別化医療の普及により、製造と品質管理はより複雑になっています。これらの治療法では、厳密なバリデーション、分析特性評価、適正製造規範（GMP）の遵守が求められ、開発・製造受託機関（CDMO）への依存度が高まっています。さらに、コスト効率とリスク軽減は、インフラへの設備投資を最小限に抑え、規制の複雑さを軽減するため、製薬企業にCMCサービスのアウトソーシングを強いる大きな要因となっています。

テクノロジーはCMCサービスのアウトソーシングをどのように変革するか？

高度な分析、人工知能（AI）、自動化の統合は、効率を高め、プロセスの失敗の可能性を低減することで、CMCサービスのアウトソーシングに革命をもたらしています。AI主導の予測モデリングは、製造ワークフローの最適化、品質管理の改善、規制文書の強化に活用されています。これにより、バッチリリースの迅速化、製造におけるばらつきの低減、製品の一貫性の向上が実現しています。もうひとつの重要な技術的進歩は、リアルタイムモニタリングとデジタルツイン技術です。これらの技術革新により、生産工程の遠隔監視が可能になり、世界の規制基準の遵守が保証されます。さらに、連続製造技術やシングルユースバイオプロセシングシステムの台頭は、CMCアウトソーシングに変革をもたらし、バイオ医薬品企業にとってよりスケーラブルで費用対効果の高いものとなっています。データ主導の洞察が普及するにつれ、企業は製品の品質と規制遵守を最適化するための情報に基づいた意思決定を行うことができるようになります。

CMCアウトソーシングの成長を牽引する業界は？

医薬品およびバイオテクノロジー部門がCMCアウトソーシングの主な促進要因であり、新規治療薬、ワクチン、バイオシミラーの開発にますます焦点が当てられています。また、細胞治療や遺伝子治療の需要も高まっており、これらの先端治療に必要な複雑な製剤、安定性試験、プロセスの最適化を管理するための専門的なCMCサービスが必要とされています。さらに、医薬品開発業務受託機関（CRO）やCDMOは、社内に製造の専門知識を持たない新興製薬企業を支援するため、その能力を拡大している。再生医療、個別化治療薬、高力価医薬品も、特殊なCMCプロトコルと厳格な世界規制への準拠を必要とするため、市場成長に寄与しています。FDA、EMA、その他の規制機関の緊張の高まりは、第三者のCMC専門知識の必要性をさらに強めています。

市場成長の要因は何か？

化学・製造・管理（CMC）サービス・アウトソーシング市場の成長は、研究開発投資の増加、規制当局による監視の強化、複雑な生物製剤や特殊医薬品の需要増加など、いくつかの要因に後押しされています。製薬会社は、分析法開発、安定性試験、製剤最適化、大規模GMP製造などの包括的ソリューションを提供できるアウトソーシング・パートナーを積極的に求めています。さらに、アジア太平洋地域の新興市場は、企業が同地域のコスト効率の高い製造能力と熟練した労働力を活用することで、CMCサービスのアウトソーシング拡大に極めて重要な役割を果たしています。また、クラウドベースの品質管理システム（QMS）の採用が進むことで、CMCコンプライアンスが合理化され、製薬企業とアウトソーシング・パートナーのシームレスな連携が可能になっています。バイオ医薬品の技術革新、自動化、規制遵守の進展に伴い、CMCサービス・アウトソーシング市場は今後数年間で力強い成長を遂げる見通しです。

セグメント

製品タイプ（原薬タイプ、最終製剤タイプ、その他タイプ）、サービスタイプ（製造サービス、薬事サービス、分析試験サービス、その他サービス）、エンドユーザー（製薬企業エンドユーザー、バイオテクノロジー企業エンドユーザー、医療機器企業エンドユーザー、その他エンドユーザー）

調査対象企業の例

• AbbVie Inc.
• Ajinomoto Bio-Pharma
• Allucent
• Ardena Holding NV
• Argonaut Manufacturing Services Inc.
• Bachem
• Boehringer Ingelheim BioXcellence
• Catalent, Inc.
• Charles River Laboratories
• CordenPharma
• Evonik Industries AG
• ICON plc
• Jubilant Life Sciences
• Pace Analytical Services
• Recipharm AB
• Samsung Biologics
• SGS（Societe Generale de Surveillance）
• Siegfried Holding AG
• Thermo Fisher Scientific
• WuXi AppTec

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Chemistry, Manufacturing and Control Services Outsourcing Market to Reach US$14.0 Billion by 2030

The global market for Chemistry, Manufacturing and Control Services Outsourcing estimated at US$10.0 Billion in the year 2024, is expected to reach US$14.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. API Type, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Finished Drug Formulation segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 9.4% CAGR

The Chemistry, Manufacturing and Control Services Outsourcing market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Chemistry, Manufacturing and Control Services Outsourcing Market - Key Trends & Drivers Summarized

Why is the Demand for CMC Services Outsourcing Increasing?

The increasing complexity of drug development and regulatory compliance is driving the demand for CMC services outsourcing. Pharmaceutical and biotech companies are facing heightened pressure to accelerate drug approval timelines while ensuring quality and safety standards. As a result, outsourcing CMC services has emerged as a strategic solution, allowing companies to focus on core competencies such as drug discovery and commercialization while delegating manufacturing and control processes to specialized third-party providers. Moreover, the growing prevalence of biologics, biosimilars, and personalized medicine has made manufacturing and quality control more intricate. These therapies require rigorous validation, analytical characterization, and compliance with Good Manufacturing Practices (GMP), increasing the reliance on contract development and manufacturing organizations (CDMOs). Additionally, cost-efficiency and risk mitigation are major factors compelling pharmaceutical firms to outsource CMC services, as it minimizes capital investment in infrastructure and reduces regulatory complexities.

How is Technology Transforming CMC Services Outsourcing?

The integration of advanced analytics, artificial intelligence (AI), and automation is revolutionizing CMC services outsourcing by enhancing efficiency and reducing the likelihood of process failures. AI-driven predictive modeling is being used to optimize manufacturing workflows, improve quality control, and enhance regulatory documentation. This has led to faster batch release, reduced variability in production, and improved product consistency. Another key technological advancement is real-time monitoring and digital twin technology. These innovations enable remote oversight of production processes, ensuring compliance with global regulatory standards. Additionally, the rise of continuous manufacturing techniques and single-use bioprocessing systems is transforming CMC outsourcing, making it more scalable and cost-effective for biopharmaceutical companies. As data-driven insights become more prevalent, companies are able to make informed decisions that optimize product quality and regulatory adherence.

Which Industries Are Driving the Growth of CMC Outsourcing?

The pharmaceutical and biotechnology sectors are the primary drivers of CMC outsourcing, with an increasing focus on developing novel therapeutics, vaccines, and biosimilars. The demand for cell and gene therapies is also rising, necessitating specialized CMC services to manage the complex formulation, stability testing, and process optimization required for these advanced treatments. In addition, contract research organizations (CROs) and CDMOs are expanding their capabilities to support emerging pharmaceutical firms that lack in-house manufacturing expertise. Regenerative medicine, personalized therapeutics, and high-potency drugs are also contributing to market growth, as these require specialized CMC protocols and compliance with stringent global regulations. The growing stringency of FDA, EMA, and other regulatory agencies is further reinforcing the need for third-party CMC expertise.

What Factors Are Fueling Market Growth?

The growth in the Chemistry, Manufacturing and Control (CMC) Services Outsourcing market is driven by several factors, including rising R&D investments, growing regulatory scrutiny, and increasing demand for complex biologics and specialty drugs. Pharmaceutical companies are actively seeking outsourcing partners that can provide comprehensive solutions for analytical method development, stability studies, formulation optimization, and large-scale GMP production. Additionally, emerging markets in Asia-Pacific are playing a pivotal role in the expansion of CMC services outsourcing, as companies leverage the region's cost-effective manufacturing capabilities and skilled workforce. The increasing adoption of cloud-based quality management systems (QMS) is also streamlining CMC compliance, enabling seamless collaboration between pharma companies and outsourcing partners. With ongoing advancements in biopharmaceutical innovation, automation, and regulatory compliance, the CMC services outsourcing market is poised for robust growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Chemistry, Manufacturing and Control Services Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (API Type, Finished Drug Formulation, Other Types); Service Type (Manufacturing Services, Regulatory Services, Analytical Testing Services, Other Services); End-Use (Pharmaceutical Companies End-Use, Biotechnological Companies End-Use, Medical Device Companies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• AbbVie Inc.
• Ajinomoto Bio-Pharma
• Allucent
• Ardena Holding NV
• Argonaut Manufacturing Services Inc.
• Bachem
• Boehringer Ingelheim BioXcellence
• Catalent, Inc.
• Charles River Laboratories
• CordenPharma
• Evonik Industries AG
• ICON plc
• Jubilant Life Sciences
• Pace Analytical Services
• Recipharm AB
• Samsung Biologics
• SGS (Societe Generale de Surveillance)
• Siegfried Holding AG
• Thermo Fisher Scientific
• WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Chemistry, Manufacturing and Control Services Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Expansion of Biologics and Cell & Gene Therapy Pipelines Drives Outsourcing Demand
  • Growing Complexity of Drug Modalities Strengthens Need for Specialized CMC Expertise
  • Cost Optimization and Faster Time-to-Market Propel Outsourcing of CMC Operations
  • Increased Adoption of Modular and Continuous Manufacturing Supports Agile Development
  • Outsourcing Demand Fueled by Small and Virtual Biopharma Companies
  • Expansion of Global CDMO Footprints Enhances Access to Regional Regulatory Know-How
  • Digitalization and Automation of CMC Workflows Improve Data Integrity and Reproducibility
  • Rise in Phase-Appropriate CMC Strategies Supports Early-Stage Development Programs
  • Focus on Analytical Method Development and Validation Enhances Quality Assurance
  • Growth in High-Potency API Production Requires Specialized CMC Infrastructure
  • Strategic Partnerships Between Sponsors and Service Providers Drive Long-Term Value
  • Use of Integrated CMC Platforms Streamlines Technology Transfer and Scale-Up
  • Demand for Accelerated IND/CTA Filing Drives Rapid CMC Package Development
  • Increased Emphasis on Tech-Enabled Project Management Enhances Collaboration
  • Expansion of Biotech Funding and IPO Activity Sustains Long-Term Outsourcing Trends
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Chemistry, Manufacturing and Control Services Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for API Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for API Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for API Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Finished Drug Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Finished Drug Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Finished Drug Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Biotechnological Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Biotechnological Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Biotechnological Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Manufacturing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Regulatory Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Analytical Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Analytical Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Analytical Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• JAPAN
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• CHINA
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• EUROPE
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• FRANCE
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• GERMANY
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• INDIA
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
• AFRICA
  • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030

IV. COMPETITION